This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market. Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision. Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report. Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions

1. Opportunity Analysis and Industry Forecast, 2016-2023
Stem Cell Umbilical Cord
Blood (UCB) Market
Trends, Cost Structure
Analysis, Growth
Opportunities
Global Opportunity Analysis and
Industry Forecast,
2012-2020

2. “Cord blood stem cell application is increasing a faster rate than other stem cell
techniques because of its efficient and cost effective treatment process. Cord blood is
assisting the healthcare industry to discover novel therapies for chronic diseases. UCB
stem cell market is evidenced significant growth due to increasing public awareness
and government support.”
Stem Cell Umbilical Cord Blood (UCB) Market

3. Allied Market Research today announced the most comprehensive and strategically
analyzed report titled World Stem Cell Umbilical Cord Blood (UCB) Market (Storage
Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends,
Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020"
Access Full Summary at : https://www.alliedmarketresearch.com/stem-cell-umbilical-
cord-blood-ucb-market
The study observed that the global umbilical cord blood stem cell market is forecasted
to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012.
Developments and approvals for novel cord blood stem cells therapies is expected to
drive the market growth. The market is expected to reach revenue of $56.4 billion by
2020, growing at CAGR of 33.4% during 2013 to 2020.The storage service market was
valued at $7.4billion in 2013.
Stem Cell Umbilical Cord Blood (UCB) Market
Overview

4. Athersys, California Stem Cell Inc., and Cytori Therapeutics Inc. are engaged in the
development of novel stem cell therapies from cord blood. Ethical issues regarding
cord blood sample application is creating biasness among donor, which is majorly
influencing the stem cell umbilical cord blood (UCB) market.
Intense competition among stem cell umbilical cord blood (UCB) market players has
been witnessed with the companies trying to create brand awareness. This is
therefore, compelling the market players to formulate market based strategies. Cord
blood stem cell is the only type of stem cell that is stored in controlled condition due
to its lower volume higher cell count feature. Storage service segment is expected
grow at 33.4% CAGR from 2013-2020 in the global stem cell umbilical cord blood (UCB)
market.
Stem Cell Umbilical Cord Blood (UCB) Market

5. According to lead analyst Debbie Shields, the geographic analysis shows that the North
American market for cord blood stem cell would account for approx. 44% of total
revenue generated by the cord blood market in 2013. However, much expected growth
is to occur in Asia-Pacific regions during the forecast period, because of growing
demand for chronic disease treatments and widely increasing awareness levels.
This report study offers updated review about major market players present in this
market such as researcher based pharmaceutical companies and therapeutics services
companies. Company profiles in this report include - Advanced Cell Technology Inc.,
California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa
Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.
Stem Cell Umbilical Cord Blood (UCB) Market,
Snapshot

6. • This report provides market intelligence with respect to therapies, applications and
storage services in cord blood stem cell market.
• Detailed analysis of top factors influencing the growth of UCB stem cell market so
that companies can take developmental decision.
• Value chain analysis, Porters five forces, top investment pockets are analysed and
presented in detail in the report.
• Intelligence of important regulatory and reimbursement issues is provided
according to geographies so that companies can take strategic decisions.
• SWOT analysis and strategic developments included in the report for Key players:
Advanced Cell Technology, Inc. (USA), Athersys, California Stem Cell Inc., Cytori
Therapeutics Inc., Mesoblast, Opexa Therapeutics Geron Corporation, Neostem Inc.
Key Benefits of Stem Cell Umbilical Cord Blood
(UCB) Market

7. Stem Cell Umbilical Cord Blood (UCB) Market
North America
Europe
Asia-Pacific
LAMEA

8. Stem Cell Umbilical Cord Blood (UCB) Market
Thank You!
For More Details
Visit us at
https://www.alliedmarketresearch.com/request-
sample/114
Follow Us On